Adnova Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.03 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.03 Cr
as on 12-12-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.24 Cr
as on 12-12-2024
- Revenue 43.91%
(FY 2022)
- Profit -175.20%
(FY 2022)
- Ebitda 23.86%
(FY 2022)
- Net Worth -9.46%
(FY 2022)
- Total Assets 10.74%
(FY 2022)
About Adnova Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.03 Cr and a paid-up capital of Rs 2.03 Cr.
The company currently has active open charges totaling ₹7.24 Cr.
Biraj Thakkar, Divyesh Sakariya, Krishna Vaghasia, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233GJ2015PTC084018
- Company No.
084018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2015
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Adnova Healthcare?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divyesh Sakariya  | Director | 03-Aug-2015 | Current |
| Biraj Thakkar | Director | 12-Jul-2019 | Current |
| Krishna Vaghasia | Director | 22-Aug-2015 | Current |
| Ramesh Pansuria | Director | 22-Aug-2015 | Current |
| Gopal Vaghasia | Director | 03-Aug-2015 | Current |
Financial Performance of Adnova Healthcare.
Adnova Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.91% increase. The company also saw a substantial fall in profitability, with a 175.2% decrease in profit. The company's net worth dipped by a decrease of 9.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adnova Healthcare?
In 2022, Adnova Healthcare had a promoter holding of 26.50% and a public holding of 73.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Android Bioscience Private LimitedActive 12 years 6 monthsDivyesh Sakariya and Gopal Vaghasia are mutual person
- Revo Medicare Private LimitedActive 12 years 5 months
Divyesh Sakariya and Gopal Vaghasia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 07 Jun 2021 | ₹1.61 Cr | Open |
Sidbi Creation Date: 08 Sep 2020 | ₹6.84 M | Open |
Sidbi Creation Date: 06 Jul 2020 | ₹5.00 M | Open |
How Many Employees Work at Adnova Healthcare?
Adnova Healthcare has a workforce of 35 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adnova Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adnova Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
